Incanthera

Incanthera is a ‘spin-out’ from the University of Bradford’s Institute of Cancer Therapeutics (the ‘ICT’). It focuses on embryonic developments in oncology. The first proposed product has the ability to deliver highly specific targeting, delivering a solution directly to the tumour source.